Molecular Mechanisms of Mitotane Action in Adrenocortical Cancer Based on In Vitro Studies
Mitotane is the only approved drug for the treatment of advanced adrenocortical carcinoma and is increasingly used for postoperative adjuvant therapy. Mitotane action involves the deregulation of cytochromes P450 enzymes, depolarization of mitochondrial membranes, and accumulation of free cholestero...
Guardado en:
Autores principales: | Marco Lo Iacono, Soraya Puglisi, Paola Perotti, Laura Saba, Jessica Petiti, Claudia Giachino, Giuseppe Reimondo, Massimo Terzolo |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0fa15dcc1fd64291ae06db3812e4c83f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Consensus on the Treatment of Adrenocortical Carcinoma with Mitotane(2021)
por: Multi-disciplinary Team for Rare Diseases, Peking Union Medical College Hospital
Publicado: (2021) -
Adrenocortical Carcinoma in Childhood: A Systematic Review
por: Maria Riedmeier, et al.
Publicado: (2021) -
The Diagnostic, Prognostic and Therapeutic Role of miRNAs in Adrenocortical Carcinoma: A Systematic Review
por: Chrysoula Mytareli, et al.
Publicado: (2021) -
Synthetic high-density lipoprotein nanodisks for targeted withalongolide delivery to adrenocortical carcinoma
por: Kuai R, et al.
Publicado: (2017) -
Expression of the Chemokine Receptor CCR7 in the Normal Adrenal Gland and Adrenal Tumors and Its Correlation with Clinical Outcome in Adrenocortical Carcinoma
por: Carmina Teresa Fuss, et al.
Publicado: (2021)